Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000176 | nuclear exosome (RNase complex) | 3 | 1 |
GO:0000177 | cytoplasmic exosome (RNase complex) | 5 | 1 |
GO:0000178 | exosome (RNase complex) | 4 | 1 |
GO:0005730 | nucleolus | 5 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
GO:1905354 | exoribonuclease complex | 3 | 1 |
Related structures:
AlphaFold database: A0A3S7WW44
Term | Name | Level | Count |
---|---|---|---|
GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 8 | 1 |
GO:0000459 | exonucleolytic trimming involved in rRNA processing | 8 | 1 |
GO:0000460 | maturation of 5.8S rRNA | 9 | 1 |
GO:0000467 | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9 | 1 |
GO:0000469 | cleavage involved in rRNA processing | 7 | 1 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 7 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006364 | rRNA processing | 8 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006399 | tRNA metabolic process | 7 | 1 |
GO:0006401 | RNA catabolic process | 5 | 1 |
GO:0006402 | mRNA catabolic process | 6 | 1 |
GO:0006417 | regulation of translation | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009057 | macromolecule catabolic process | 4 | 1 |
GO:0009889 | regulation of biosynthetic process | 4 | 1 |
GO:0009890 | negative regulation of biosynthetic process | 5 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0009894 | regulation of catabolic process | 4 | 1 |
GO:0009896 | positive regulation of catabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 6 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010629 | negative regulation of gene expression | 6 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0016072 | rRNA metabolic process | 7 | 1 |
GO:0016073 | snRNA metabolic process | 7 | 1 |
GO:0016075 | rRNA catabolic process | 7 | 1 |
GO:0016078 | tRNA catabolic process | 7 | 1 |
GO:0016180 | snRNA processing | 8 | 1 |
GO:0017148 | negative regulation of translation | 7 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0019439 | aromatic compound catabolic process | 4 | 1 |
GO:0031123 | RNA 3'-end processing | 7 | 1 |
GO:0031125 | rRNA 3'-end processing | 9 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031325 | positive regulation of cellular metabolic process | 5 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
GO:0031327 | negative regulation of cellular biosynthetic process | 6 | 1 |
GO:0031329 | regulation of cellular catabolic process | 5 | 1 |
GO:0031331 | positive regulation of cellular catabolic process | 6 | 1 |
GO:0034248 | regulation of amide metabolic process | 5 | 1 |
GO:0034249 | negative regulation of amide metabolic process | 6 | 1 |
GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' | 9 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034472 | snRNA 3'-end processing | 8 | 1 |
GO:0034473 | U1 snRNA 3'-end processing | 9 | 1 |
GO:0034475 | U4 snRNA 3'-end processing | 9 | 1 |
GO:0034476 | U5 snRNA 3'-end processing | 9 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0034661 | ncRNA catabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043487 | regulation of RNA stability | 3 | 1 |
GO:0043488 | regulation of mRNA stability | 4 | 1 |
GO:0043628 | regulatory ncRNA 3'-end processing | 8 | 1 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 1 |
GO:0043633 | polyadenylation-dependent RNA catabolic process | 6 | 1 |
GO:0043634 | polyadenylation-dependent ncRNA catabolic process | 7 | 1 |
GO:0043928 | exonucleolytic catabolism of deadenylated mRNA | 9 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 1 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 1 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0046700 | heterocycle catabolic process | 4 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048522 | positive regulation of cellular process | 4 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050779 | RNA destabilization | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051246 | regulation of protein metabolic process | 5 | 1 |
GO:0051248 | negative regulation of protein metabolic process | 6 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051254 | positive regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 1 |
GO:0061014 | positive regulation of mRNA catabolic process | 7 | 1 |
GO:0061157 | mRNA destabilization | 5 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0071025 | RNA surveillance | 6 | 1 |
GO:0071027 | nuclear RNA surveillance | 7 | 1 |
GO:0071028 | nuclear mRNA surveillance | 8 | 1 |
GO:0071029 | nuclear ncRNA surveillance | 7 | 1 |
GO:0071035 | nuclear polyadenylation-dependent rRNA catabolic process | 8 | 1 |
GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process | 8 | 1 |
GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process | 7 | 1 |
GO:0071046 | nuclear polyadenylation-dependent ncRNA catabolic process | 8 | 1 |
GO:0071047 | polyadenylation-dependent mRNA catabolic process | 6 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 7 | 1 |
GO:0106354 | tRNA surveillance | 7 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 1 |
GO:1903313 | positive regulation of mRNA metabolic process | 7 | 1 |
GO:2000112 | obsolete regulation of cellular macromolecule biosynthetic process | 6 | 1 |
GO:2000113 | obsolete negative regulation of cellular macromolecule biosynthetic process | 7 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 357 | 361 | PF00656 | 0.661 |
CLV_C14_Caspase3-7 | 81 | 85 | PF00656 | 0.550 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.509 |
CLV_NRD_NRD_1 | 283 | 285 | PF00675 | 0.503 |
CLV_NRD_NRD_1 | 34 | 36 | PF00675 | 0.403 |
CLV_NRD_NRD_1 | 343 | 345 | PF00675 | 0.469 |
CLV_PCSK_FUR_1 | 135 | 139 | PF00082 | 0.533 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.534 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.403 |
CLV_PCSK_KEX2_1 | 343 | 345 | PF00082 | 0.469 |
CLV_PCSK_SKI1_1 | 149 | 153 | PF00082 | 0.426 |
CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.389 |
DEG_APCC_DBOX_1 | 137 | 145 | PF00400 | 0.451 |
DEG_SPOP_SBC_1 | 185 | 189 | PF00917 | 0.692 |
DOC_CYCLIN_RxL_1 | 250 | 262 | PF00134 | 0.407 |
DOC_MAPK_DCC_7 | 254 | 263 | PF00069 | 0.329 |
DOC_MAPK_gen_1 | 107 | 114 | PF00069 | 0.456 |
DOC_MAPK_gen_1 | 135 | 143 | PF00069 | 0.392 |
DOC_MAPK_gen_1 | 254 | 263 | PF00069 | 0.344 |
DOC_MAPK_MEF2A_6 | 107 | 114 | PF00069 | 0.389 |
DOC_MAPK_MEF2A_6 | 254 | 263 | PF00069 | 0.350 |
DOC_PP1_RVXF_1 | 283 | 290 | PF00149 | 0.394 |
DOC_PP2B_LxvP_1 | 256 | 259 | PF13499 | 0.414 |
DOC_USP7_MATH_1 | 185 | 189 | PF00917 | 0.709 |
DOC_USP7_MATH_1 | 192 | 196 | PF00917 | 0.699 |
DOC_USP7_MATH_1 | 201 | 205 | PF00917 | 0.678 |
DOC_USP7_MATH_1 | 271 | 275 | PF00917 | 0.605 |
DOC_USP7_MATH_1 | 353 | 357 | PF00917 | 0.536 |
DOC_USP7_MATH_1 | 56 | 60 | PF00917 | 0.496 |
DOC_USP7_MATH_1 | 78 | 82 | PF00917 | 0.372 |
DOC_USP7_MATH_1 | 91 | 95 | PF00917 | 0.588 |
DOC_USP7_UBL2_3 | 281 | 285 | PF12436 | 0.351 |
DOC_WW_Pin1_4 | 186 | 191 | PF00397 | 0.594 |
DOC_WW_Pin1_4 | 298 | 303 | PF00397 | 0.334 |
DOC_WW_Pin1_4 | 41 | 46 | PF00397 | 0.589 |
DOC_WW_Pin1_4 | 76 | 81 | PF00397 | 0.363 |
LIG_14-3-3_CanoR_1 | 284 | 290 | PF00244 | 0.440 |
LIG_APCC_ABBA_1 | 225 | 230 | PF00400 | 0.452 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.650 |
LIG_BIR_III_2 | 115 | 119 | PF00653 | 0.388 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.526 |
LIG_FHA_1 | 70 | 76 | PF00498 | 0.366 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.361 |
LIG_FHA_2 | 309 | 315 | PF00498 | 0.348 |
LIG_FHA_2 | 398 | 404 | PF00498 | 0.433 |
LIG_FHA_2 | 95 | 101 | PF00498 | 0.619 |
LIG_LIR_Apic_2 | 195 | 199 | PF02991 | 0.553 |
LIG_LIR_Apic_2 | 262 | 267 | PF02991 | 0.501 |
LIG_LIR_Apic_2 | 314 | 319 | PF02991 | 0.490 |
LIG_LIR_Apic_2 | 364 | 368 | PF02991 | 0.553 |
LIG_LIR_Gen_1 | 139 | 148 | PF02991 | 0.473 |
LIG_LIR_Gen_1 | 288 | 297 | PF02991 | 0.347 |
LIG_LIR_Gen_1 | 376 | 385 | PF02991 | 0.499 |
LIG_LIR_Gen_1 | 63 | 69 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 139 | 143 | PF02991 | 0.496 |
LIG_LIR_Nem_3 | 376 | 381 | PF02991 | 0.510 |
LIG_LIR_Nem_3 | 63 | 67 | PF02991 | 0.506 |
LIG_NRBOX | 294 | 300 | PF00104 | 0.322 |
LIG_PDZ_Class_3 | 400 | 405 | PF00595 | 0.506 |
LIG_SH2_CRK | 264 | 268 | PF00017 | 0.579 |
LIG_SH2_CRK | 337 | 341 | PF00017 | 0.411 |
LIG_SH2_PTP2 | 365 | 368 | PF00017 | 0.558 |
LIG_SH2_PTP2 | 64 | 67 | PF00017 | 0.484 |
LIG_SH2_SRC | 64 | 67 | PF00017 | 0.484 |
LIG_SH2_STAP1 | 124 | 128 | PF00017 | 0.389 |
LIG_SH2_STAP1 | 247 | 251 | PF00017 | 0.413 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.436 |
LIG_SH2_STAT5 | 218 | 221 | PF00017 | 0.399 |
LIG_SH2_STAT5 | 334 | 337 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 365 | 368 | PF00017 | 0.602 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 64 | 67 | PF00017 | 0.503 |
LIG_SH3_1 | 42 | 48 | PF00018 | 0.477 |
LIG_SH3_3 | 304 | 310 | PF00018 | 0.341 |
LIG_SH3_3 | 363 | 369 | PF00018 | 0.625 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.581 |
LIG_SH3_4 | 281 | 288 | PF00018 | 0.403 |
LIG_SUMO_SIM_par_1 | 296 | 301 | PF11976 | 0.353 |
MOD_CK1_1 | 186 | 192 | PF00069 | 0.728 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.650 |
MOD_CK1_1 | 356 | 362 | PF00069 | 0.550 |
MOD_CK1_1 | 370 | 376 | PF00069 | 0.578 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.630 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.728 |
MOD_CK2_1 | 308 | 314 | PF00069 | 0.334 |
MOD_CK2_1 | 397 | 403 | PF00069 | 0.412 |
MOD_CK2_1 | 6 | 12 | PF00069 | 0.412 |
MOD_CK2_1 | 60 | 66 | PF00069 | 0.406 |
MOD_CK2_1 | 94 | 100 | PF00069 | 0.716 |
MOD_GlcNHglycan | 125 | 128 | PF01048 | 0.522 |
MOD_GlcNHglycan | 190 | 193 | PF01048 | 0.728 |
MOD_GlcNHglycan | 203 | 206 | PF01048 | 0.527 |
MOD_GlcNHglycan | 236 | 239 | PF01048 | 0.528 |
MOD_GlcNHglycan | 356 | 359 | PF01048 | 0.577 |
MOD_GlcNHglycan | 369 | 372 | PF01048 | 0.530 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.566 |
MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.720 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.674 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.531 |
MOD_GSK3_1 | 349 | 356 | PF00069 | 0.607 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.509 |
MOD_GSK3_1 | 397 | 404 | PF00069 | 0.421 |
MOD_GSK3_1 | 56 | 63 | PF00069 | 0.508 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.650 |
MOD_N-GLC_1 | 60 | 65 | PF02516 | 0.509 |
MOD_N-GLC_1 | 67 | 72 | PF02516 | 0.500 |
MOD_N-GLC_1 | 91 | 96 | PF02516 | 0.649 |
MOD_N-GLC_2 | 375 | 377 | PF02516 | 0.410 |
MOD_NEK2_1 | 143 | 148 | PF00069 | 0.312 |
MOD_NEK2_1 | 183 | 188 | PF00069 | 0.539 |
MOD_NEK2_1 | 234 | 239 | PF00069 | 0.495 |
MOD_NEK2_2 | 259 | 264 | PF00069 | 0.347 |
MOD_PIKK_1 | 397 | 403 | PF00454 | 0.307 |
MOD_PKA_2 | 100 | 106 | PF00069 | 0.682 |
MOD_Plk_4 | 259 | 265 | PF00069 | 0.342 |
MOD_Plk_4 | 361 | 367 | PF00069 | 0.601 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.428 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.319 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.289 |
MOD_ProDKin_1 | 186 | 192 | PF00069 | 0.593 |
MOD_ProDKin_1 | 298 | 304 | PF00069 | 0.341 |
MOD_ProDKin_1 | 41 | 47 | PF00069 | 0.595 |
MOD_ProDKin_1 | 76 | 82 | PF00069 | 0.366 |
TRG_DiLeu_BaEn_2 | 220 | 226 | PF01217 | 0.445 |
TRG_DiLeu_BaLyEn_6 | 290 | 295 | PF01217 | 0.458 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.461 |
TRG_ENDOCYTIC_2 | 337 | 340 | PF00928 | 0.440 |
TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.503 |
TRG_ER_diArg_1 | 107 | 110 | PF00400 | 0.339 |
TRG_ER_diArg_1 | 136 | 138 | PF00400 | 0.448 |
TRG_ER_diArg_1 | 34 | 36 | PF00400 | 0.408 |
TRG_Pf-PMV_PEXEL_1 | 29 | 33 | PF00026 | 0.422 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PD98 | Leptomonas seymouri | 69% | 95% |
A0A0S4JA55 | Bodo saltans | 28% | 100% |
A0A1X0NWT9 | Trypanosomatidae | 44% | 100% |
A0A3R7M9T9 | Trypanosoma rangeli | 49% | 100% |
A4HYX8 | Leishmania infantum | 100% | 100% |
C9ZII6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9AIJ0 | Leishmania braziliensis | 82% | 100% |
E9AUS5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4QCR0 | Leishmania major | 93% | 100% |
V5D565 | Trypanosoma cruzi | 45% | 100% |